Novoeight HCP Email: “Meet Vaughn, who lives with hemophilia A” Jun 26, 2018Jun 24, 2018 Brand: Novoeight (antihemophilic factor), Intravenous Infusion Parent Company: Novo Nordisk Drug Type: Prescription Drug Category: Hematology Campaign: Post-Launch Targeting: HCPs Patient Website: https://www.novoeight.com/ HCP Website: https://www.novoeightpro.com/ Received: June 20, 2018 at 7:02 AM Subject: Meet Vaughn, who lives with hemophilia A From: Novo Nordisk